सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

a. menarini singapore pte. ltd. - dexketoprofen trometamol eqv dexketoprofen - tablet, film coated - 25mg - dexketoprofen trometamol eqv dexketoprofen 25mg

केन्या - अंग्रेज़ी - Pharmacy and Poisons Board

menarini international operations luxembourg s.a 1 avenue de la gare l1611 luxembourg - dexketoprofen (as trometamol salt) - film-coated tablet - 25 mg - non-steroidal

पनामा - अंग्रेज़ी - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios fermon, s.l. - beclometasona dipropionato - beclometasona dipropionato....0.125 mg.

सऊदी अरब - अंग्रेज़ी - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratorios cinfa sa, spain - escitalopram - film-coated tablet - 10 mg

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. ciambra is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. (miol) - ranolazine - angina pectoris - cardiac therapy - ranexa is indicated as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line anti-anginal therapies (such as beta-blockers and / or calcium antagonists).,

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4.2, 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 500mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 375mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 750mg